I guess this shows clearly the stark contrast in size between the US and Australian markets.
I don’t know the number of SOI of Alpine or Vertex. But PYC will soon have 4.7 billion SOI.
At $1/share PYC would have a MCAP of $4.7 billion.
At $10/ share the MCAP would be $47 billion. (About 20% of C S L’s)
I don’t see any reason why that sort of MCAP is unrealistic for PYC, given the number of patients and the number of treatments in the pipeline. Provided of course, that they are effective and without SAE.
I guess this shows clearly the stark contrast in size between...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.0¢ | $358.4K | 3.354M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 130000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 2500 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.005 ( 1.16 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 11.0¢ | 10.0¢ | 1085435 | ||
| Last updated 15.58pm 03/05/2024 ? | |||||
| PYC (ASX) Chart |